CEBPA and acute myeloid leukemia: As our study has already demonstrated the efficient targeting and delivery of MTL-CEBPA to the bone marrow microenvironment, investigating the immunomodulatory effects of MTL-CEBPA in AML could be a future research avenue to sensitize the AML immune microenvironment to ICIs.